Cargando…

CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy

Detalles Bibliográficos
Autores principales:	Wang, Hong-Juan, Ma, Cong, Yang, Jie, Xu, Qiang, Zhang, Yan, Gao, Lei, Xu, Bin, Zhang, Yu-Xiao, Li, Yang, Yin, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418912/ https://www.ncbi.nlm.nih.gov/pubmed/23097648 http://dx.doi.org/10.3724/SP.J.1263.2012.04162

Ejemplares similares

Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
por: Li, Jie-Hui, et al.
Publicado: (2012)

Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients
por: Chen, Peng, et al.
Publicado: (2016)

Warfarin-quetiapine interaction causing hemorrhage
por: Bavle, Amar D., et al.
Publicado: (2016)

Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
por: Jia, LiQun, et al.
Publicado: (2017)

Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis
por: Zhang, Jinhua, et al.
Publicado: (2016)

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
por: Zhang, J. E., et al.
Publicado: (2017)

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers
por: Nie, Shanshan, et al.
Publicado: (2022)

CYP4F2 and CYP3A5 gene polymorphisms and lung cancer in Chinese Han population
por: He, Ruiqing, et al.
Publicado: (2020)

Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan
por: AL-Eitan, Laith N., et al.
Publicado: (2021)

Frequency of polymorphisms in the CYP2C9, VKORC1, and CYP4F2 genes related to the metabolism of Warfarin in healthy donors from Cali, Colombia
por: Giraldo-Ocampo, Sebastian, et al.
Publicado: (2023)

A Rare and Lethal Complication of Oral Warfarin Therapy
por: Mahto, Subodh Kumar, et al.
Publicado: (2019)

Correlation between Rs2108622 Locus of CYP4F2 Gene Single Nucleotide Polymorphism and Warfarin Dosage in Iranian Cardiovascular Patients
por: Khosropanah, Shahdah, et al.
Publicado: (2017)

CYP2C9*3 polymorphism presenting as lethal subdural hematoma with low-dose warfarin
por: Karnik, Niteen D., et al.
Publicado: (2014)

Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation
por: Li, Jiao, et al.
Publicado: (2018)

Warfarin: Major bleeding complication manifesting as retroperitoneal bleed: case report
Publicado: (2020)

Association of CYP2J2 gene polymorphisms with ischemic stroke and stroke subtypes in Chinese population
por: Wang, Si-Yang, et al.
Publicado: (2017)

The Contribution of VKORC1 and CYP2C9 Genetic Polymorphisms and Patients’ Demographic Characteristics with Warfarin Maintenance Doses: A Suggested Warfarin Dosing Algorithm
por: Khaleqsefat, Esmat, et al.
Publicado: (2020)

Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population
por: Wang, Dongxu, et al.
Publicado: (2022)

Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population
por: Hadjipanagi, Despina, et al.
Publicado: (2014)

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy
por: Poopak, Behzad, et al.
Publicado: (2015)

The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population
por: Mao, Yan, et al.
Publicado: (2020)

Effects of VKORC1 Genetic Polymorphisms on Warfarin Maintenance Dose Requirement in a Chinese Han Population
por: Yan, Xiaojuan, et al.
Publicado: (2015)

Methylation of CYP1A1 and VKORC1 promoter associated with stable dosage of warfarin in Chinese patients
por: He, Shiwei, et al.
Publicado: (2021)

Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis
por: Takeuchi, Masanobu, et al.
Publicado: (2016)

Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population
por: Taşkın, Birce Dilge, et al.
Publicado: (2016)

CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population
por: Yu, Changqing, et al.
Publicado: (2014)

Suggestive evidence of CYP4F2 gene polymorphisms with HAPE susceptibility in the Chinese Han population
por: Si, Lining, et al.
Publicado: (2023)

Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
por: Agrawal, Saaket, et al.
Publicado: (2020)

Warfarin-Induced Intracerebral Hemorrhage Associated with Microbleeds
por: Lee, Gha-Hyun, et al.
Publicado: (2008)

Reversal of Warfarin-Induced Hemorrhage in the Emergency Department
por: Zareh, Meena, et al.
Publicado: (2011)

Location and Characteristics of Warfarin Associated Intracranial Hemorrhage
por: Lee, Sang-Min, et al.
Publicado: (2014)

Hemorrhagic bullous dermatosis caused by warfarin therapy
por: Ferguson, Annie, et al.
Publicado: (2016)

Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy
por: Kaya, Bülent, et al.
Publicado: (2015)

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
por: Takeuchi, Fumihiko, et al.
Publicado: (2009)

Is the use of warfarin becoming obsolete?
por: Haykal, Tarek, et al.
Publicado: (2021)

Impact of polymorphisms of the GGCX gene on maintenance warfarin dose in Chinese populations: Systematic review and meta-analysis
por: Tian, Lihong, et al.
Publicado: (2015)

Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses
por: Yee, Jeong, et al.
Publicado: (2019)

Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction
por: Kringen, Marianne K., et al.
Publicado: (2011)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
por: Shahabi, Payman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jb5qlsfa3hvf0tkdb3e0jnr030